237 related articles for article (PubMed ID: 34334569)
1. Immunotherapy-responsive Non-paraneoplastic Encephalitis with Antibodies against GAD, LGI1, and GABA
Nakano T; Chihara N; Matoba K; Tachibana H; Okuda S; Otsuka Y; Ueda T; Sekiguchi K; Kowa H; Leypoldt F; Wandinger KP; Matsumoto R
Intern Med; 2022 Feb; 61(3):419-423. PubMed ID: 34334569
[TBL] [Abstract][Full Text] [Related]
2. Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy.
Kishitani T; Matsunaga A; Ikawa M; Hayashi K; Yamamura O; Hamano T; Watanabe O; Tanaka K; Nakamoto Y; Yoneda M
Medicine (Baltimore); 2017 Mar; 96(10):e6181. PubMed ID: 28272206
[TBL] [Abstract][Full Text] [Related]
3. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune encephalitis with coexistent LGI1 and GABA
Xie Y; Wen J; Zhao Z; Liu H; Xie N
BMC Neurol; 2021 Nov; 21(1):461. PubMed ID: 34836497
[TBL] [Abstract][Full Text] [Related]
6. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
[TBL] [Abstract][Full Text] [Related]
7. Bi-Basal Ganglia Involvement with Signal Evolution in a Case of Anti-LGI1 Encephalitis.
Gai Q; Ruan S; Dong X; Cong S
Neurol India; 2022; 70(1):384-386. PubMed ID: 35263922
[TBL] [Abstract][Full Text] [Related]
8. Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapy.
Mueller C; Elben S; Day GS; Alves P; Hebert J; Tang-Wai DF; Holtmann O; Iorio R; Perani D; Titulaer MJ; Hansen N; Bartsch T; Johnen A; Illes Z; Borm L; Willison AG; Wiendl H; Meuth SG; Kovac S; Bölte J; Melzer N
Clin Neurol Neurosurg; 2023 Jan; 224():107559. PubMed ID: 36549220
[TBL] [Abstract][Full Text] [Related]
9. Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.
Orimo K; Iwata NK; Kawai M; Nakajima H; Takeda K; Murai H; Goto J
Intern Med; 2021 Sep; 60(18):3021-3024. PubMed ID: 33055478
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune Epilepsy.
Gaspard N
Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):227-45. PubMed ID: 26844739
[TBL] [Abstract][Full Text] [Related]
11. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune encephalitis as differential diagnosis of infectious encephalitis.
Armangue T; Leypoldt F; Dalmau J
Curr Opin Neurol; 2014 Jun; 27(3):361-8. PubMed ID: 24792345
[TBL] [Abstract][Full Text] [Related]
13. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.
Hansen N; Widman G; Witt JA; Wagner J; Becker AJ; Elger CE; Helmstaedter C
Epilepsy Behav; 2016 Dec; 65():18-24. PubMed ID: 27855355
[TBL] [Abstract][Full Text] [Related]
14. Anti-gamma-aminobutyric acid receptor type A encephalitis: a review.
Guo CY; Gelfand JM; Geschwind MD
Curr Opin Neurol; 2020 Jun; 33(3):372-380. PubMed ID: 32374573
[TBL] [Abstract][Full Text] [Related]
15. MRI Characteristics of Autoimmune Encephalitis With Autoantibodies to GABAA Receptor: A Case Series.
Deng B; Cai M; Qiu Y; Liu X; Yu H; Zhang X; Huang H; Zhao X; Yang W; Dong S; Jin L; Chu S; Chen X
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35338092
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.
Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T
JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis.
Ohkawa T; Satake S; Yokoi N; Miyazaki Y; Ohshita T; Sobue G; Takashima H; Watanabe O; Fukata Y; Fukata M
J Neurosci; 2014 Jun; 34(24):8151-63. PubMed ID: 24920620
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune encephalitis and seizures, cerebrospinal fluid, imaging, and EEG findings: a case series.
Elkhider H; Sharma R; Kapoor N; Vattoth S; Shihabuddin B
Neurol Sci; 2022 Apr; 43(4):2669-2680. PubMed ID: 34564782
[TBL] [Abstract][Full Text] [Related]
20. Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report.
Hou L; Wan L; Li H; Wang Z; Guan H; Ren H; Wang P
BMC Neurol; 2022 Jul; 22(1):281. PubMed ID: 35896991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
